BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15355933)

  • 1. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
    Charnaux N; Brule S; Chaigneau T; Saffar L; Sutton A; Hamon M; Prost C; Lievre N; Vita C; Gattegno L
    Glycobiology; 2005 Feb; 15(2):119-30. PubMed ID: 15355933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.
    Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
    Glycobiology; 2003 Sep; 13(9):623-34. PubMed ID: 12773479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
    Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
    Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
    Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
    FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).
    Hamon M; Mbemba E; Charnaux N; Slimani H; Brule S; Saffar L; Vassy R; Prost C; Lievre N; Starzec A; Gattegno L
    Glycobiology; 2004 Apr; 14(4):311-23. PubMed ID: 15033938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells.
    Andrian E; Grenier D; Rouabhia M
    J Cell Physiol; 2005 Jul; 204(1):178-83. PubMed ID: 15648090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.
    Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
    Biochim Biophys Acta; 2003 Oct; 1617(1-2):80-8. PubMed ID: 14637022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase.
    Fitzgerald ML; Wang Z; Park PW; Murphy G; Bernfield M
    J Cell Biol; 2000 Feb; 148(4):811-24. PubMed ID: 10684261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.
    Subramanian SV; Fitzgerald ML; Bernfield M
    J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on enterocyte shedding of syndecan-1 and associated decreases in internalization of Listeria monocytogenes and Staphylococcus aureus.
    Henry-Stanley MJ; Zhang B; Erlandsen SL; Wells CL
    Cytokine; 2006 Jun; 34(5-6):252-9. PubMed ID: 16884912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement.
    Roscic-Mrkic B; Fischer M; Leemann C; Manrique A; Gordon CJ; Moore JP; Proudfoot AE; Trkola A
    Blood; 2003 Aug; 102(4):1169-77. PubMed ID: 12714503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
    Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
    J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
    Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
    Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence.
    Park PW; Pier GB; Hinkes MT; Bernfield M
    Nature; 2001 May; 411(6833):98-102. PubMed ID: 11333985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: a proposed mechanism for stabilization of extracellular lipoprotein lipase.
    Reizes O; Goldberger O; Smith AC; Xu Z; Bernfield M; Bickel PE
    Biochemistry; 2006 May; 45(18):5703-11. PubMed ID: 16669614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
    Lim JK; Burns JM; Lu W; DeVico AL
    J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells.
    Asundi VK; Erdman R; Stahl RC; Carey DJ
    J Neurosci Res; 2003 Sep; 73(5):593-602. PubMed ID: 12929127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG; Peehl DM; Kadam PA; Lawrence DM
    Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.